Show
Sort by
-
Re-188-HDD/Lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial
-
Comparison of the real-life radiation burden to relatives of patients treated with I-131-Lipiodol or Re-188-HDD/Lipiodol
-
Biologic dosimetry of Re-188-HDD/lipiodol versus I-131-lipiodol therapy in patients with hepatocellular carcinoma
-
Biodistribution and dosimetry of Tc-99m-depreotide (P829) in patients suffering from breast carcinoma
-
Radiolabeling, biodistribution, and dosimetry of I-123-mAb 14C5: A new mAb for radioimmunodetection of tumor growth and metastasis in vivo
-
Patient doses in gamma-intracoronary radiotherapy: The radiation burden assessment study
-
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study
-
Development, pharmaceutical validation and radioprotection properties of a new concept of 188W/188Re generator
-
Locoregionale I-131 lipiodol therapie bij de behandeling van het hepatocellulair carcinoom
-
In vitro evaluation of Bi-213-rituximab versus external gamma irradiation for the treatment of B-CLL patients: relative biological efficacy with respect to apoptosis induction and chromosomal damage